China’s Innovation Surge: R&D Investments Propel New Productive Forces
China’s final year of the 14th Five-Year Plan emphasizes new quality productive forces, driven by substantial R&D investments and advancements in high-tech sectors.
RandD
Read More
AstraZeneca Plans to Launch 100 New Medicines in China by 2029
AstraZeneca’s EVP Sharon Barr reveals the company’s plans to launch 100 new medicines in China over the next five years, highlighting mutual interests with Chinese collaborators.
China’s Economic Future Shines Bright: Expert Predicts Robust Growth in 2024
Li Daokui forecasts China’s GDP to grow between 5.7% and 5.8% in 2024, driven by strong savings, extensive R&D, and a massive consumer market.